Organovo Holdings Inc (ONVO)
1.01
-0.04
(-3.81%)
USD |
NASDAQ |
Apr 23, 16:00
1.01
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Cash from Investing (TTM): 0.641M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.641M |
September 30, 2023 | 10.59M |
June 30, 2023 | 10.49M |
March 31, 2023 | -0.966M |
December 31, 2022 | -0.857M |
September 30, 2022 | -10.96M |
June 30, 2022 | -10.91M |
March 31, 2022 | -0.409M |
December 31, 2021 | -0.467M |
September 30, 2021 | -0.623M |
June 30, 2021 | -0.589M |
March 31, 2021 | -0.393M |
December 31, 2020 | -0.263M |
September 30, 2020 | 0.727M |
June 30, 2020 | 0.748M |
March 31, 2020 | 0.747M |
December 31, 2019 | 0.686M |
September 30, 2019 | -0.04M |
June 30, 2019 | -0.077M |
March 31, 2019 | -0.076M |
December 31, 2018 | -0.166M |
September 30, 2018 | -0.175M |
June 30, 2018 | -0.209M |
March 31, 2018 | -0.292M |
December 31, 2017 | -0.442M |
Date | Value |
---|---|
September 30, 2017 | -1.065M |
June 30, 2017 | -1.46M |
March 31, 2017 | -1.391M |
December 31, 2016 | -1.512M |
September 30, 2016 | -1.016M |
June 30, 2016 | -1.012M |
March 31, 2016 | -2.135M |
December 31, 2015 | -2.382M |
September 30, 2015 | -2.512M |
June 30, 2015 | -2.414M |
March 31, 2015 | -1.517M |
December 31, 2014 | -0.988M |
September 30, 2014 | -0.718M |
June 30, 2014 | -0.393M |
March 31, 2014 | -0.268M |
December 31, 2013 | -0.2479M |
September 30, 2013 | -0.4025M |
June 30, 2013 | -0.5142M |
December 31, 2012 | -0.445M |
September 30, 2012 | -0.3441M |
June 30, 2012 | -0.1685M |
March 31, 2012 | -0.0438M |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | -0.03M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-10.96M
Minimum
Sep 2022
10.59M
Maximum
Sep 2023
-0.1015M
Average
-0.263M
Median
Dec 2020
Cash from Investing (TTM) Benchmarks
Marinus Pharmaceuticals Inc | -28.60M |
Cartesian Therapeutics Inc | 34.61M |
Adial Pharmaceuticals Inc | -- |
Longeveron Inc | 8.186M |
Viracta Therapeutics Inc | 15.00M |